Clinical trial
Hepatic Artery Infusion of CD34+ Cells
NCT00062543 · M.D. Anderson Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00062543 |
|---|---|
| Title | Hepatic Artery Infusion of CD34+ Cells |
| Official title | Hepatic Artery Infusion of CD34+ Cells, Isolated by the Isolex 300i Device, in Stem Cell Transplant Recipients With Hepatic Failure Due to Veno-occlusive Disease |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Stem Cell Transplantation, Liver Diseases |
| Intervention type | Device, Procedure |
| Interventions | Hepatic artery infusion of CD34+ cells, Cobe Spectra |
| Enrollment | 0 |
| Start date | May 1, 2002 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Jun 12, 2003 |
| Last update posted | Oct 29, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: